Alice C. O’Farrell

Author

Alice C. O’Farrell

Royal College of Surgeons in Ireland ORCID

Also Known As

A C O’Farrell, A. C. O’Farrell, A.C O’Farrell, A.C. O'Farrell, A.C. O’Farrell, AC O'Farrell, Alice C O’Farrell, Alice C. O'Farrell, Alice C. O’Farrell, Alice O'Farrell

Publications

661

Citations

H-Index

Concepts

All Affiliations

Royal College of Surgeons in Ireland VIB-KU Leuven Center for Cancer Biology University College Dublin Beaumont Hospital Candiolo Cancer Institute

About

Alice C. O’Farrell is an author at Royal College of Surgeons in Ireland specializing in oxidative stress, cardiovascular pharmacology, and molecular imaging.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	1	1	13
2	Health Sciences	1	1	29
3	Medicine	1	1	29
4	Biochemistry	1	1	29
5	Biomedical Engineering	1	1	13

Alice C. O’Farrell

Publications

473

Citations

H-Index

Page 1

	Year	Citations
Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts Xing Yi Woo, Jessica Giordano, Anuj Srivastava, Nature Genetics	2021	188
Identification, validation and biological characterisation of novel glioblastoma tumour microenvironment subtypes: implications for precision immunotherapy Kirsten A. White, Kate Connor, Maxime Meylan, Annals of Oncology	2022	118
Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts Xing Yi Woo, Jessica Giordano, Anuj Srivastava,	2019	33
A Novel Positron Emission Tomography (PET) Approach to Monitor Cardiac Metabolic Pathway Remodeling in Response to Sunitinib Malate Alice C. O’Farrell, Rhys L. Evans, Johanna M. U. Silvola, PLoS ONE Mitochondrial DysfunctionCardiovascular PharmacologyMetabolic RemodelingCardiovascular ToxicityRedox Biology	2017	29
Ex vivo drug sensitivity screening predicts response to temozolomide in glioblastoma patients and identifies candidate biomarkers Ioannis Ntafoulis, Anne Kleijn, Jie Ju, British Journal of Cancer	2023	28
Implementing Systems Modelling and Molecular Imaging to Predict the Efficacy of BCL-2 Inhibition in Colorectal Cancer Patient-Derived Xenograft Models Alice C. O’Farrell, Monika A. Jarzabek, Andreas U. Lindner, Cancers	2020	19
Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis of candidate circulating markers of cardiac toxicity: ICORG 08–10 trial Giuseppe Gullo, Alex J. Eustace, Alexandra Canonici, Therapeutic Advances in Medical Oncology	2019	14
RGD-decorated cholesterol stabilized polyplexes for targeted siRNA delivery to glioblastoma cells Bo Lou, Kate Connor, Kieron J. Sweeney, Drug Delivery and Translational Research Cell-based Drug DeliveryNanomedicineEngineeringPolymer-drug ConjugateRna Interference	2019	13
Comparative analysis of deeply phenotyped GBM cohorts of ‘short-term’ and ‘long-term’ survivors Archita Biswas, Manuela Salvucci, Kate Connor, Journal of Neuro-Oncology	2023	11
Anti-angiogenic drug scheduling optimisation with application to colorectal cancer Marc Sturrock, Ian S. Miller, Guolian Kang, Scientific Reports	2018	10

Page 1